FR18C1032I1 - - Google Patents
Info
- Publication number
- FR18C1032I1 FR18C1032I1 FR18C1032C FR18C1032I1 FR 18C1032 I1 FR18C1032 I1 FR 18C1032I1 FR 18C1032 C FR18C1032 C FR 18C1032C FR 18C1032 I1 FR18C1032 I1 FR 18C1032I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007034018 | 2007-02-14 | ||
PCT/JP2008/052918 WO2008099969A1 (ja) | 2007-02-14 | 2008-02-14 | 抗fgf23抗体及びそれを含む医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR18C1032I1 true FR18C1032I1 (es) | 2018-08-31 |
FR18C1032I2 FR18C1032I2 (fr) | 2019-08-09 |
Family
ID=39690189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR18C1032C Active FR18C1032I2 (fr) | 2007-02-14 | 2018-07-27 | Anticorps anti-fgf23 et composition pharmaceutique le comprenant |
Country Status (23)
Country | Link |
---|---|
US (4) | US7883705B2 (es) |
EP (3) | EP3181691B1 (es) |
JP (1) | JP4800396B2 (es) |
KR (1) | KR101462291B1 (es) |
CN (2) | CN102702355B (es) |
AU (1) | AU2008215346B2 (es) |
CA (1) | CA2677782C (es) |
CY (3) | CY1118835T1 (es) |
DK (3) | DK3181691T3 (es) |
ES (3) | ES2530670T3 (es) |
FR (1) | FR18C1032I2 (es) |
HK (2) | HK1140228A1 (es) |
HR (2) | HRP20170548T1 (es) |
HU (3) | HUE031728T2 (es) |
LT (3) | LT3181691T (es) |
LU (2) | LUC00081I2 (es) |
NL (1) | NL300945I2 (es) |
NO (1) | NO2018025I1 (es) |
PL (3) | PL2128253T3 (es) |
PT (3) | PT2502996T (es) |
SI (2) | SI3181691T1 (es) |
TW (1) | TWI422593B (es) |
WO (1) | WO2008099969A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001280096B2 (en) * | 2000-08-11 | 2007-03-22 | Kyowa Kirin Co., Ltd. | Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
ES2331414T3 (es) * | 2001-12-28 | 2010-01-04 | Kyowa Hakko Kirin Co Ltd | Anticuerpos contra el factor 23 de crecimiento de fibroblastos. |
US7883705B2 (en) * | 2007-02-14 | 2011-02-08 | Kyowa Hakko Kirin Co., Ltd. | Anti FGF23 antibody and a pharmaceutical composition comprising the same |
WO2012050673A1 (en) * | 2010-10-14 | 2012-04-19 | Wisconsin Alumni Research Foundation | Methods for the treatment of x-linked hypophosphatemia and related disorders |
WO2012177481A2 (en) | 2011-06-24 | 2012-12-27 | University Of Miami | Fibroblast growth factor receptor inhibition for the treatment of disease |
KR20170013993A (ko) * | 2014-06-09 | 2017-02-07 | 울트라제닉스 파마수티컬 인코포레이티드 | 최적의 골 형성을 위한 혈청 포스페이트의 효과적이고 효율적인 조절 |
WO2018069232A1 (en) | 2016-10-10 | 2018-04-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of having cardiac hypertrophy |
CN110494561A (zh) | 2017-03-30 | 2019-11-22 | 希森美康株式会社 | 抗ApoA1抗体 |
WO2020205523A1 (en) * | 2019-03-29 | 2020-10-08 | Atarga, Llc | Anti fgf23 antibody |
WO2024034638A1 (ja) * | 2022-08-10 | 2024-02-15 | 協和キリン株式会社 | 抗fgf23抗体又は該抗体断片 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623587A (en) | 1979-08-03 | 1981-03-05 | Mitsuwa Seiki Co Ltd | Vane type compressor |
WO1985003934A1 (en) | 1984-03-06 | 1985-09-12 | Takeda Chemical Industries, Ltd. | Chemically modified protein and process for its preparation |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
JPS61178926U (es) | 1985-04-23 | 1986-11-08 | ||
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
FI884924A (fi) | 1987-10-28 | 1989-04-29 | Oncogen | Humanimmuglobulin som producerats med hybrid-dna-teknik. |
JP2958019B2 (ja) | 1988-05-06 | 1999-10-06 | 住友製薬株式会社 | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5958879A (en) | 1989-10-12 | 1999-09-28 | Ohio University/Edison Biotechnology Institute | Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal |
US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
US6001358A (en) | 1995-11-07 | 1999-12-14 | Idec Pharmaceuticals Corporation | Humanized antibodies to human gp39, compositions containing thereof |
EP1086225B1 (en) | 1998-05-18 | 2007-02-21 | University College London | Human tumour-derived polypeptide hormone phosphatonin |
TWI255853B (en) | 1998-08-21 | 2006-06-01 | Kirin Brewery | Method for modifying chromosomes |
AU3924300A (en) | 1999-04-02 | 2000-10-23 | Millennium Pharmaceuticals, Inc. | Fibroblast growth factor-20 |
US6596849B1 (en) | 1999-05-28 | 2003-07-22 | Academia Sinica | Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules |
ATE478145T1 (de) | 1999-06-02 | 2010-09-15 | Genentech Inc | Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren |
JP2004522404A (ja) | 1999-12-01 | 2004-07-29 | ジェネンテック・インコーポレーテッド | 分泌及び膜貫通ポリペプチドとそれをコードしている核酸 |
AU784469B2 (en) | 1999-12-08 | 2006-04-06 | Serono Genetics Institute S.A. | Full-length human cDNAs encoding potentially secreted proteins |
AU2759201A (en) | 2000-01-05 | 2001-07-16 | Zymogenetics Inc. | Novel fgf homolog zfgf12 |
EP1255771A4 (en) | 2000-02-14 | 2004-09-29 | Smithkline Beecham Corp | NEW COMPOUNDS |
CA2398603A1 (en) | 2000-02-15 | 2001-08-23 | Amgen, Inc. | Fibroblast growth factor-23 molecules and uses thereof |
US20060160181A1 (en) * | 2000-02-15 | 2006-07-20 | Amgen Inc. | Fibroblast Growth Factor-23 molecules and uses thereof |
WO2001066595A2 (en) | 2000-03-08 | 2001-09-13 | Chiron Corporation | Human fgf-23 gene and gene expression products |
WO2001066596A2 (en) | 2000-03-08 | 2001-09-13 | Chiron Corporation | Human fgf-23 gene and gene expression products |
CN1446227B (zh) | 2000-07-19 | 2011-10-05 | 先端研究与技术学院 | 新型成纤维细胞生长因子(fgf23)及其使用方法 |
AU2001280096B2 (en) | 2000-08-11 | 2007-03-22 | Kyowa Kirin Co., Ltd. | Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
MXPA03004793A (es) | 2000-11-30 | 2004-12-03 | Medarex Inc | Roedores transgenicos transcromosomales para elaborar anticuerpos humnanos. |
WO2002076467A1 (en) | 2001-03-22 | 2002-10-03 | Genzyme Corporation | Compositions and methods to regulate bone and mineral metabolism |
JP2004527253A (ja) | 2001-04-26 | 2004-09-09 | ジーンプロット・インコーポレイテッド | 線維芽細胞成長因子−23分子およびその使用 |
PT1391464E (pt) * | 2001-04-27 | 2007-11-15 | Kirin Pharma Kk | Anticorpo monoclonal anti-cd40 |
ES2331414T3 (es) | 2001-12-28 | 2010-01-04 | Kyowa Hakko Kirin Co Ltd | Anticuerpos contra el factor 23 de crecimiento de fibroblastos. |
US7094551B2 (en) | 2002-09-17 | 2006-08-22 | Zahradnik Richard J | Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23 |
US20070036734A1 (en) * | 2003-03-17 | 2007-02-15 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for periodontal disease |
DK1753783T3 (en) * | 2004-06-03 | 2014-11-17 | Novlmmune Sa | Anti-CD3 antibodies, and methods of use thereof |
CN102942631B (zh) * | 2004-08-05 | 2015-03-25 | 健泰科生物技术公司 | 人源化抗c-met拮抗剂 |
CN101010427B (zh) * | 2004-09-06 | 2011-07-27 | 协和发酵麒麟株式会社 | 抗a33抗体 |
JPWO2006078072A1 (ja) | 2005-01-21 | 2008-06-19 | キリンファーマ株式会社 | キメラ非ヒト動物およびその使用 |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US20100062984A1 (en) * | 2007-01-25 | 2010-03-11 | Rajiv Kumar | Fgf-23 polypeptides |
US7883705B2 (en) * | 2007-02-14 | 2011-02-08 | Kyowa Hakko Kirin Co., Ltd. | Anti FGF23 antibody and a pharmaceutical composition comprising the same |
-
2008
- 2008-02-13 US US12/030,593 patent/US7883705B2/en active Active
- 2008-02-14 EP EP17152168.5A patent/EP3181691B1/en active Active
- 2008-02-14 CA CA2677782A patent/CA2677782C/en active Active
- 2008-02-14 PT PT121709844T patent/PT2502996T/pt unknown
- 2008-02-14 PL PL08711707T patent/PL2128253T3/pl unknown
- 2008-02-14 ES ES08711707T patent/ES2530670T3/es active Active
- 2008-02-14 HU HUE12170984A patent/HUE031728T2/en unknown
- 2008-02-14 LT LTEP17152168.5T patent/LT3181691T/lt unknown
- 2008-02-14 SI SI200832131T patent/SI3181691T1/sl unknown
- 2008-02-14 KR KR1020097019085A patent/KR101462291B1/ko active Protection Beyond IP Right Term
- 2008-02-14 DK DK17152168.5T patent/DK3181691T3/da active
- 2008-02-14 CN CN201210161119.8A patent/CN102702355B/zh active Active
- 2008-02-14 LT LTEP12170984.4T patent/LT2502996T/lt unknown
- 2008-02-14 PL PL12170984T patent/PL2502996T3/pl unknown
- 2008-02-14 ES ES12170984T patent/ES2625823T3/es active Active
- 2008-02-14 PT PT171521685T patent/PT3181691T/pt unknown
- 2008-02-14 HU HUE17152168A patent/HUE050517T2/hu unknown
- 2008-02-14 DK DK08711707.3T patent/DK2128253T3/en active
- 2008-02-14 PT PT87117073T patent/PT2128253E/pt unknown
- 2008-02-14 ES ES17152168T patent/ES2811318T3/es active Active
- 2008-02-14 WO PCT/JP2008/052918 patent/WO2008099969A1/ja active Application Filing
- 2008-02-14 CN CN2008800048145A patent/CN101652476B/zh active Active
- 2008-02-14 EP EP12170984.4A patent/EP2502996B1/en active Active
- 2008-02-14 SI SI200831797T patent/SI2502996T1/sl unknown
- 2008-02-14 PL PL17152168T patent/PL3181691T3/pl unknown
- 2008-02-14 TW TW097105234A patent/TWI422593B/zh active
- 2008-02-14 AU AU2008215346A patent/AU2008215346B2/en active Active
- 2008-02-14 EP EP08711707.3A patent/EP2128253B1/en active Active
- 2008-02-14 LU LU00081C patent/LUC00081I2/en unknown
- 2008-02-14 JP JP2008558165A patent/JP4800396B2/ja active Active
- 2008-02-14 DK DK12170984.4T patent/DK2502996T3/en active
- 2008-02-14 LU LU00082C patent/LUC00082I2/en unknown
-
2010
- 2010-06-28 HK HK10106310.8A patent/HK1140228A1/xx unknown
-
2011
- 2011-02-02 US US13/019,557 patent/US9290569B2/en active Active
-
2013
- 2013-01-04 HK HK13100123.5A patent/HK1172917A1/xx unknown
-
2016
- 2016-02-10 US US15/040,103 patent/US10202446B2/en active Active
-
2017
- 2017-04-04 HR HRP20170548TT patent/HRP20170548T1/hr unknown
- 2017-04-19 CY CY20171100446T patent/CY1118835T1/el unknown
-
2018
- 2018-07-27 NL NL300945C patent/NL300945I2/en unknown
- 2018-07-27 FR FR18C1032C patent/FR18C1032I2/fr active Active
- 2018-08-01 LT LTPA2018508C patent/LTC2502996I2/lt unknown
- 2018-08-02 HU HUS1800034C patent/HUS1800034I1/hu unknown
- 2018-08-07 CY CY2018021C patent/CY2018021I2/el unknown
- 2018-08-09 NO NO2018025C patent/NO2018025I1/no unknown
- 2018-12-18 US US16/223,930 patent/US20190106485A1/en not_active Abandoned
-
2020
- 2020-08-03 CY CY20201100713T patent/CY1123240T1/el unknown
- 2020-08-11 HR HRP20201266TT patent/HRP20201266T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR18C1032I1 (es) | ||
CN300730826S (zh) | 蜡烛(153) | |
CN300872530S (zh) | 编织帘片材(b007140) | |
CN300864067S (zh) | 砂轮(33) | |
CN300851266S (zh) | 纺织面料(2007163) | |
CN300844626S (zh) | 净化加湿器(yz-ds2008) | |
CN300726288S (zh) | 装饰玻璃(幸运草) | |
CN300726717S (zh) | 刀柄(a01) | |
CN300726718S (zh) | 刀柄 | |
CN301017871S (zh) | 床(儒雅风华h3308d) | |
CN300727151S (zh) | 包装袋(魔力钾) | |
CN300727228S (zh) | 电子压力控制器(skd-3) | |
CN300727398S (zh) | 汽车后保险杠 | |
CN300727415S (zh) | 金属轮毂(371) | |
CN300727452S (zh) | 手机充电器(中田07a) | |
CN300838886S (zh) | 包装盒(880g中老年燕麦片) | |
CN300727459S (zh) | 电源适配器(1) | |
CN300727769S (zh) | 单压吸收式制冷机 | |
CN300727859S (zh) | 笔(sm1016) | |
CN300727958S (zh) | 标牌(预防接种麻疹疫苗) | |
CN300728235S (zh) | 烟筒 | |
CN300730197S (zh) | 雕刻机(一) | |
CN300730026S (zh) | 音响(迷你) | |
CN300730245S (zh) | 订书机(pod-05) | |
CN300729859S (zh) | 控制杆 |